Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea

scientific article published on 25 July 2006

Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/506354
P698PubMed publication ID16886144

P2093author name stringFiona Smaill
Marek Smieja
Christine Lee
Danny Lagrotteria
Serena Holmes
P433issue5
P921main subjectdiarrheaQ40878
metronidazoleQ169569
Clostridium difficileQ310543
rifampicinQ422652
P304page(s)547-552
P577publication date2006-07-25
P1433published inClinical Infectious DiseasesQ5133764
P1476titleProspective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea
P478volume43

Reverse relations

cites work (P2860)
Q42063601Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations
Q24234378Antibiotic treatment for Clostridium difficile -associated diarrhea in adults
Q24244302Antibiotic treatment for Clostridium difficile-associated diarrhea in adults
Q30235446Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults
Q83025404Can metronidazole still be used for treatment of Clostridium difficile infections?
Q56225357Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
Q37633859Clinical update for the diagnosis and treatment of Clostridium difficile infection
Q38445227Clostridium Difficile Infection from a Surgical Perspective.
Q35208564Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.
Q37305032Clostridium difficile infection in the intensive care unit
Q24632641Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance
Q36757577Clostridium difficile-associated disease: changing epidemiology and implications for management
Q36871148Clostridium difficile: The evolving story
Q38538221Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection
Q41832378Current Treatment Options for Severe Clostridium difficile-associated Disease
Q26786662Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis
Q35164536Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections
Q47577721Measurement of selected preventable adverse drug events in electronic health records: Toward developing a complexity score
Q45325656National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014.
Q37052819New advances in the treatment of Clostridium difficile infection (CDI)
Q34602195New antimicrobial agents for patients with Clostridium difficile infections
Q55405974Novel Antimicrobials for the Treatment of Clostridium difficile Infection.
Q36098158On Lactococcus lactis UL719 competitivity and nisin (Nisaplin(®)) capacity to inhibit Clostridium difficile in a model of human colon
Q37875055Recurrent Clostridium difficile infection: what are the treatment options?
Q85170619Rifampin plus Metronidazole for Clostridium difficile Infection
Q43168261The A, B, BI, and Cs of Clostridium difficile
Q28082059The potential for emerging therapeutic options for Clostridium difficile infection
Q36270659Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination
Q37050248Update on the changing epidemiology of Clostridium difficile-associated disease
Q30417830Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice

Search more.